CLINICAL_TRIALS
trial_result
· 2014-07-21
Clinical Trial Update: Phase 2 Hyper-CVAD/Rituximab for Untreated Mantle Cell Lymphoma [Phase 2]
Summary
Phase 2 trial update for untreated mantle cell lymphoma using Hyper-CVAD/rituximab; study completed with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Wisconsin, Madison | Conditions: Mantle Cell Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2014-07-21